Home / Dermatology
Dermatology
| 3 min read
Janssen reports that the drug achieved primary and secondary endpoints in its Phase 3 trial
| 3 min read
Patients respond well to Aclaris’ ATI-501 in alopecia areata trial
| 1 min read
New ‘Vilnius-made’ method reportedly reduces DNA testing costs by 90 percent
| 2 min read
From a Focus Feature to Q&As, there's no shortage of bonus pieces in our October issue; no matter which indications interest you most, there's something for everyone
| 3 min read
Amgen to acquire psoriasis and psoriatic arthritis drug for $13.4 billion
| 2 min read
LifeSpan BioSciences announces the acquisition of Everest Biotech
| 3 min read
FDA releases final guidance on how interchangeability will be determined for biosimilars
| 2 min read
ASLAN Pharmaceuticals has acquired full global commercial rights for ASLAN004 from CSL
| 3 min read
MorphoSys announces that licensee Janssen has expanded clinical development of drug into familial adenomatous polyposis
